These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
875 related items for PubMed ID: 16943255
1. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol. McMahon LR. J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255 [Abstract] [Full Text] [Related]
2. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol. McMahon LR. Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389 [Abstract] [Full Text] [Related]
3. Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice. McMahon LR, Ginsburg BC, Lamb RJ. Psychopharmacology (Berl); 2008 Jul; 198(4):487-95. PubMed ID: 17673980 [Abstract] [Full Text] [Related]
5. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats. Zaniewska M, McCreary AC, Przegaliński E, Filip M. Eur J Pharmacol; 2006 Jul 01; 540(1-3):96-106. PubMed ID: 16730696 [Abstract] [Full Text] [Related]
6. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice. McMahon LR, Koek W. Eur J Pharmacol; 2007 Aug 13; 569(1-2):70-6. PubMed ID: 17553486 [Abstract] [Full Text] [Related]
7. Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs. Stewart JL, McMahon LR. J Pharmacol Exp Ther; 2010 Jul 13; 334(1):347-56. PubMed ID: 20375197 [Abstract] [Full Text] [Related]
8. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells. McCollum L, Howlett AC, Mukhopadhyay S. J Pharmacol Exp Ther; 2007 Jun 13; 321(3):930-7. PubMed ID: 17379772 [Abstract] [Full Text] [Related]
9. JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects. Rodriguez JS, McMahon LR. Eur J Pharmacol; 2014 Oct 05; 740():151-9. PubMed ID: 24972243 [Abstract] [Full Text] [Related]
11. Chronic Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids. McMahon LR. Br J Pharmacol; 2011 Mar 05; 162(5):1060-73. PubMed ID: 21091643 [Abstract] [Full Text] [Related]
12. Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinol. McMahon LR. Psychopharmacology (Berl); 2009 Apr 05; 203(2):219-28. PubMed ID: 18592221 [Abstract] [Full Text] [Related]
13. Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys. Wiley JL, Lowe JA, Balster RL, Martin BR. J Pharmacol Exp Ther; 1995 Oct 05; 275(1):1-6. PubMed ID: 7562536 [Abstract] [Full Text] [Related]
14. Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed. Duncan M, Kendall DA, Ralevic V. J Pharmacol Exp Ther; 2004 Oct 05; 311(1):411-9. PubMed ID: 15205450 [Abstract] [Full Text] [Related]
15. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat. Craft RM, Wakley AA, Tsutsui KT, Laggart JD. J Pharmacol Exp Ther; 2012 Mar 05; 340(3):787-800. PubMed ID: 22182934 [Abstract] [Full Text] [Related]
16. Apparent Affinity Estimates and Reversal of the Effects of Synthetic Cannabinoids AM-2201, CP-47,497, JWH-122, and JWH-250 by Rimonabant in Rhesus Monkeys. Hruba L, McMahon LR. J Pharmacol Exp Ther; 2017 Aug 05; 362(2):278-286. PubMed ID: 28533288 [Abstract] [Full Text] [Related]
17. Discriminative stimulus effects of the structurally novel cannabinoid CB1/CB2 receptor partial agonist BAY 59-3074 in the rat. De Vry J, Jentzsch KR. Eur J Pharmacol; 2004 Nov 28; 505(1-3):127-33. PubMed ID: 15556145 [Abstract] [Full Text] [Related]
18. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids. Ihenetu K, Molleman A, Parsons ME, Whelan CJ. Eur J Pharmacol; 2003 Jan 01; 458(1-2):207-15. PubMed ID: 12498928 [Abstract] [Full Text] [Related]